دورية أكاديمية

Single-dose Intravenous Ondansetron in Children with Gastroenteritis: A Randomized Controlled Trial.

التفاصيل البيبلوغرافية
العنوان: Single-dose Intravenous Ondansetron in Children with Gastroenteritis: A Randomized Controlled Trial.
المؤلفون: Rang NN; Department of Pediatrics, Can Tho University of Medicine and Pharmacy, Vietnam. Correspondence to: Dr Nguyen Ngoc Rang, Pediatric Department of Can Tho University of Medicine and Pharmacy, 179 Nguyen Van Cu, Can Tho, Vietnam. nguyenngocrang@gmail.com., Chanh TQ; Department of Pediatrics, An Giang Hospital, Vietnam., My PT; Department of Pediatrics, An Giang Hospital, Vietnam., Tien TTM; Department of Pediatrics, An Giang Hospital, Vietnam.
المصدر: Indian pediatrics [Indian Pediatr] 2019 Jun 15; Vol. 56 (6), pp. 468-471.
نوع المنشور: Journal Article; Randomized Controlled Trial
اللغة: English
بيانات الدورية: Publisher: Indian Pediatrics Country of Publication: India NLM ID: 2985062R Publication Model: Print Cited Medium: Internet ISSN: 0974-7559 (Electronic) Linking ISSN: 00196061 NLM ISO Abbreviation: Indian Pediatr Subsets: MEDLINE
أسماء مطبوعة: Publication: New Delhi : Indian Pediatrics
Original Publication: Bombay.
مواضيع طبية MeSH: Antiemetics/*therapeutic use , Dehydration/*prevention & control , Gastroenteritis/*complications , Ondansetron/*therapeutic use , Vomiting/*drug therapy, Child, Preschool ; Dehydration/etiology ; Dehydration/therapy ; Diarrhea/etiology ; Double-Blind Method ; Drug Administration Schedule ; Female ; Fluid Therapy/statistics & numerical data ; Gastroenteritis/therapy ; Humans ; Infant ; Injections, Intravenous ; Length of Stay/statistics & numerical data ; Male ; Treatment Outcome ; Vomiting/etiology
مستخلص: Objective: To evaluate the efficacy of ondansetron for the treatment of vomiting and thus reducing the need for intravenous (IV) rehydration in children with gastroenteritis.
Design: Double-blind, placebo-controlled, randomized trial.
Setting: Pediatric ward of An Giang General Hospital, South Vietnam, between December 2013 and June 2014.
Participants: 61 inpatient children (age 11-60 mo) suffering from gastroenteritis with vomiting. Exclusion criteria were: underlying chronic conditions, immunodeficiency, malnutrition or history of allergy to ondansetron.
Intervention: Single bolus of IV ondansetron at a dose of 0.2 mg/kg or placebo.
Outcome Measures: Proportion of patients who needed IV rehydration, proportion of patients with cessation of vomiting, amount of oral rehydration solution intake, duration of diarrhea and the length of hospital stay.
Results: After drug administration, 22 (73%) of the 30 patients in the ondansetron group had complete cessation of vomiting compared with 7 (23%) of the 31 patients in the placebo group (RR 0.32; 95% CI 0.16 to 0.63, P<0.001). 3 (10%) patients in the ondansetron group required IV rehydration as compared with 12 (39%) in the placebo group (RR 0.51; 95% CI 0.33 to 0.79, P=0.009). The median amount of oral rehydration solution intake in 24 hours was significantly greater in the ondansetron group (450 mL vs 350 mL, P=0.019).The duration of diarrhea and the length of hospital stay were not different between the two groups.
Conclusions: In hospitalized children having gastro-enteritis associated with emesis, ondansetron is effective in the cessation of episodes of vomiting and in lowering the rates of IV rehydration, without reducing the duration of diarrhea and hospital stay.
التعليقات: Comment in: Indian Pediatr. 2019 Oct 15;56(10):887-888. (PMID: 31724552)
Comment in: Indian Pediatr. 2019 Oct 15;56(10):888. (PMID: 31724553)
المشرفين على المادة: 0 (Antiemetics)
4AF302ESOS (Ondansetron)
تواريخ الأحداث: Date Created: 20190707 Date Completed: 20200204 Latest Revision: 20200204
رمز التحديث: 20240628
PMID: 31278225
قاعدة البيانات: MEDLINE